AGL stock forecast, quote, news & analysis
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients... Show more
Why agilon health (AGL) Is Up +118% in the Last 30 Days
Key Takeaways
- agilon health (AGL) stock surged +118% over the past 30 days, driven by a 1-for-25 reverse stock split and renewed investor optimism around improving fundamentals.
- The stock experienced high volatility, peaking near $31 before pulling back, amid sector momentum in healthcare services.
- Over the past quarter, AGL is up a modest +1%, reflecting recovery from lows near $8 following Q4 earnings.
- Key catalysts include better-than-expected Q4 revenue, forward guidance for near break-even EBITDA in 2026, and positive peer performance.
- Reverse stock split helped maintain Nasdaq listing compliance and boosted share price perception.
- Upcoming Q1 2026 earnings on May 6 could influence near-term sentiment.
agilon health (AGL) Company Overview and Market Position
agilon health, inc. (NYSE: AGL) is a healthcare services company that partners with primary care physicians (PCPs) to deliver a total care payment model for senior patients. The company's platform enables PCPs to manage the total cost of care through value-based arrangements with payors, focusing on Medicare Advantage plans. agilon provides technology, data analytics, and operational support to facilitate risk-bearing contracts, where physicians share in savings from efficient care delivery.
In the competitive healthcare industry, agilon differentiates through its physician-centric approach in the growing value-based care segment. With exposure to senior demographics and Medicare trends, its business model benefits from rising demand for cost-effective care amid aging populations. Recent stock behavior aligns with improving operational metrics and sector tailwinds, despite past challenges like membership declines.
agilon health (AGL) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, AGL stock rose +118%, from a close of $11.00 on March 23 to $24.01 on April 21. The movement was highly volatile and trend-driven upward, with a sharp post-split rally peaking at $30.94 on April 16 before a pullback. Trading volume spiked during the advance, reflecting heightened investor interest.
For the past quarter, the stock gained +1%, moving from $23.83 on January 21 to $24.01. Performance was range-bound with significant volatility, dipping to a low of $7.91 in late March before recovering. The quarter featured a steady recovery phase after earnings, punctuated by the reverse split impact.
What Drove AGL Stock Price in the Last 30 Days
The primary catalyst was agilon health's 1-for-25 reverse stock split, effective March 30, which adjusted shares to boost the per-share price and aid Nasdaq compliance. Post-split, the stock surged as investors reassessed its turnaround potential, fueled by Q4 2025 results showing revenue of $1.57 billion—beating estimates by 7.2%—despite an EPS miss.
Sector sentiment shifted positively, with AGL shares soaring alongside peers like Astrana Health and Evolent Health amid broader healthcare momentum. Analyst actions, including a "Buy" rating with a raised price target, added tailwinds. Improving vitals, such as guidance for near break-even EBITDA in 2026 versus prior-year losses, enhanced market confidence, driving the volatile uptrend in stock price analysis.
What Drove AGL Stock Performance Over the Last Quarter
The quarter's modest +1% gain stemmed from sustained narratives around operational improvements and strategic moves. Q4 earnings in late February highlighted revenue growth but underscored losses, leading to an initial dip; however, forward guidance signaled progress toward profitability, supporting recovery.
The reverse stock split addressed listing risks, restoring investor appeal. Macro factors like Medicare Advantage enrollment trends and value-based care adoption provided a favorable backdrop. Institutional interest grew as peers advanced, with AGL benefiting from comparative strength in outpatient and specialty care benchmarking. Cumulative impact from these elements offset volatility, stabilizing price movement.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI-driven trading bots from a library of hundreds scanning thousands of tickers. These curated bots employ diverse strategies, including trend-following, mean reversion, and momentum plays, across various timeframes from intraday to long-term. Performance metrics such as win rate, average return, and Sharpe ratio highlight their edge, with only the most relevant and high-achieving models featured based on recent market conditions. Traders can explore, backtest, and deploy these bots to enhance their stock analysis and automate trades. Visit the page to discover bots tailored to current market trends.
AGL Stock Forecast Drivers: What Investors Should Watch Next
Investors should monitor Q1 2026 earnings on May 6 for updates on revenue, membership, and EBITDA progress toward 2026 guidance. Industry trends in value-based care and Medicare policy changes could impact risk-bearing contracts. Macroeconomic factors like healthcare spending and inflation in medical costs remain key. Strategic developments, including partnerships or platform expansions, may signal growth. Risks include execution on cost controls and competition, while catalysts like analyst revisions or peer earnings could sway sentiment in market trends.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
AGL in downward trend: price may decline as a result of having broken its higher Bollinger Band on June 11, 2026
AGL broke above its upper Bollinger Band on June 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 34 similar instances where the stock broke above the upper band. In of the 34 cases the stock fell afterwards. This puts the odds of success at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on June 04, 2026. You may want to consider a long position or call options on AGL as a result. In of 74 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AGL just turned positive on June 11, 2026. Looking at past instances where AGL's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
The 50-day moving average for AGL moved above the 200-day moving average on May 13, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AGL advanced for three days, in of 274 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 146 cases where AGL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.384) is normal, around the industry mean (219.600). P/E Ratio (0.000) is within average values for comparable stocks, (120.574). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.424). AGL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (0.322) is also within normal values, averaging (2.486).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AGL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry HospitalNursingManagement